메뉴 건너뛰기




Volumn 354, Issue 9, 2006, Pages 975-

Acute oxygen-sensing mechanisms [8]

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; OXYGEN; ANGIOTENSIN II; HYPOXIA INDUCIBLE FACTOR 1; AMYLOID BETA PROTEIN; CALCIUM; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

EID: 33644594324     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMc053396     Document Type: Letter
Times cited : (6)

References (5)
  • 2
    • 0036978227 scopus 로고    scopus 로고
    • Is "somatic" angiotensin I-converting enzyme a mechanosensor?
    • Moskowitz DW. Is "somatic" angiotensin I-converting enzyme a mechanosensor? Diabetes Technol Ther 2002;4:841-58.
    • (2002) Diabetes Technol Ther , vol.4 , pp. 841-858
    • Moskowitz, D.W.1
  • 3
    • 4544369788 scopus 로고    scopus 로고
    • The central role of angiotensin I-converting enzyme in vertebrate pathophysiology
    • Moskowitz DW, Johnson FE. The central role of angiotensin I-converting enzyme in vertebrate pathophysiology. Curr Top Med Chem 2004;4:1433-54.
    • (2004) Curr Top Med Chem , vol.4 , pp. 1433-1454
    • Moskowitz, D.W.1    Johnson, F.E.2
  • 4
    • 0036412170 scopus 로고    scopus 로고
    • Is angiotensin I-converting enzyme a "master" disease gene?
    • Moskowitz DW. Is angiotensin I-converting enzyme a "master" disease gene? Diabetes Technol Ther 2002;4:683-711.
    • (2002) Diabetes Technol Ther , vol.4 , pp. 683-711
    • Moskowitz, D.W.1
  • 5
    • 0036382632 scopus 로고    scopus 로고
    • From pharmacogenomics to improved patient outcomes: Angiotensin I-converting enzyme as an example
    • Moskowitz DW. Idem. From pharmacogenomics to improved patient outcomes: angiotensin I-converting enzyme as an example. Diabetes Technol Ther 2002;4:519-32.
    • (2002) Diabetes Technol Ther , vol.4 , pp. 519-532
    • Moskowitz, D.W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.